FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012309329> ?p ?o ?g. }

• W2012309329 endingPage "461" @default.
• W2012309329 startingPage "437" @default.
• W2012309329 abstract "Antioxidants specifically addressed to mitochondria have been studied to determine if they can decelerate senescence of organisms. For this purpose, a project has been established with participation of several research groups from Russia and some other countries. This paper summarizes the first results of the project. A new type of compounds (SkQs) comprising plastoquinone (an antioxidant moiety), a penetrating cation, and a decane or pentane linker has been synthesized. Using planar bilayer phospholipid membrane (BLM), we selected SkQ derivatives with the highest permeability, namely plastoquinonyl-decyl-triphenylphosphonium (SkQ1), plastoquinonyl-decyl-rhodamine 19 (SkQR1), and methylplastoquinonyldecyltriphenylphosphonium (SkQ3). Anti- and prooxidant properties of these substances and also of ubiquinonyl-decyl-triphenylphosphonium (MitoQ) were tested in aqueous solution, detergent micelles, liposomes, BLM, isolated mitochondria, and cell cultures. In mitochondria, micromolar cationic quinone derivatives were found to be prooxidants, but at lower (sub-micromolar) concentrations they displayed antioxidant activity that decreases in the series SkQ1=SkQR1>SkQ3>MitoQ. SkQ1 was reduced by mitochondrial respiratory chain, i.e. it is a rechargeable antioxidant. Nanomolar SkQ1 specifically prevented oxidation of mitochondrial cardiolipin. In cell cultures, SkQR1, a fluorescent SkQ derivative, stained only one type of organelles, namely mitochondria. Extremely low concentrations of SkQ1 or SkQR1 arrested H(2)O(2)-induced apoptosis in human fibroblasts and HeLa cells. Higher concentrations of SkQ are required to block necrosis initiated by reactive oxygen species (ROS). In the fungus Podospora anserina, the crustacean Ceriodaphnia affinis, Drosophila, and mice, SkQ1 prolonged lifespan, being especially effective at early and middle stages of aging. In mammals, the effect of SkQs on aging was accompanied by inhibition of development of such age-related diseases and traits as cataract, retinopathy, glaucoma, balding, canities, osteoporosis, involution of the thymus, hypothermia, torpor, peroxidation of lipids and proteins, etc. SkQ1 manifested a strong therapeutic action on some already pronounced retinopathies, in particular, congenital retinal dysplasia. With drops containing 250 nM SkQ1, vision was restored to 67 of 89 animals (dogs, cats, and horses) that became blind because of a retinopathy. Instillation of SkQ1-containing drops prevented the loss of sight in rabbits with experimental uveitis and restored vision to animals that had already become blind. A favorable effect of the same drops was also achieved in experimental glaucoma in rabbits. Moreover, the SkQ1 pretreatment of rats significantly decreased the H(2)O(2) or ischemia-induced arrhythmia of the isolated heart. SkQs strongly reduced the damaged area in myocardial infarction or stroke and prevented the death of animals from kidney ischemia. In p53(-/-) mice, 5 nmol/kgxday SkQ1 decreased the ROS level in the spleen and inhibited appearance of lymphomas to the same degree as million-fold higher concentration of conventional antioxidant NAC. Thus, SkQs look promising as potential tools for treatment of senescence and age-related diseases." @default.
• W2012309329 created "2016-06-24" @default.
• W2012309329 creator A5004217035 @default.
• W2012309329 creator A5006298977 @default.
• W2012309329 creator A5008043744 @default.
• W2012309329 creator A5013740551 @default.
• W2012309329 creator A5021100324 @default.
• W2012309329 creator A5022594605 @default.
• W2012309329 creator A5024371860 @default.
• W2012309329 creator A5026191193 @default.
• W2012309329 creator A5026738278 @default.
• W2012309329 creator A5030568682 @default.
• W2012309329 creator A5038219811 @default.
• W2012309329 creator A5045616453 @default.
• W2012309329 creator A5050082035 @default.
• W2012309329 creator A5054201517 @default.
• W2012309329 creator A5055381157 @default.
• W2012309329 creator A5056961645 @default.
• W2012309329 creator A5062719301 @default.
• W2012309329 creator A5063639723 @default.
• W2012309329 creator A5064185691 @default.
• W2012309329 creator A5064857408 @default.
• W2012309329 creator A5065320376 @default.
• W2012309329 creator A5066599605 @default.
• W2012309329 creator A5070594128 @default.
• W2012309329 creator A5078120151 @default.
• W2012309329 creator A5090750733 @default.
• W2012309329 creator A5091338270 @default.
• W2012309329 creator A5091434212 @default.
• W2012309329 date "2009-05-01" @default.
• W2012309329 modified "2023-10-11" @default.
• W2012309329 title "An attempt to prevent senescence: A mitochondrial approach" @default.
• W2012309329 cites W103075655 @default.
• W2012309329 cites W1498174224 @default.
• W2012309329 cites W1509549356 @default.
• W2012309329 cites W1520227874 @default.
• W2012309329 cites W1552605193 @default.
• W2012309329 cites W1963545628 @default.
• W2012309329 cites W1965009601 @default.
• W2012309329 cites W1966778713 @default.
• W2012309329 cites W1967327510 @default.
• W2012309329 cites W1967701846 @default.
• W2012309329 cites W1970607230 @default.
• W2012309329 cites W1971215002 @default.
• W2012309329 cites W1975045295 @default.
• W2012309329 cites W1976139410 @default.
• W2012309329 cites W1976202841 @default.
• W2012309329 cites W1978170936 @default.
• W2012309329 cites W1978437552 @default.
• W2012309329 cites W1978933175 @default.
• W2012309329 cites W1985977889 @default.
• W2012309329 cites W1986997254 @default.
• W2012309329 cites W1987981231 @default.
• W2012309329 cites W1988058885 @default.
• W2012309329 cites W1988655372 @default.
• W2012309329 cites W1989711396 @default.
• W2012309329 cites W1990999065 @default.
• W2012309329 cites W1992225748 @default.
• W2012309329 cites W1992423211 @default.
• W2012309329 cites W1993838026 @default.
• W2012309329 cites W1995219619 @default.
• W2012309329 cites W1996728254 @default.
• W2012309329 cites W1996885665 @default.
• W2012309329 cites W2000405107 @default.
• W2012309329 cites W2002301670 @default.
• W2012309329 cites W2005038133 @default.
• W2012309329 cites W2005381354 @default.
• W2012309329 cites W2005809472 @default.
• W2012309329 cites W2009494221 @default.
• W2012309329 cites W2010077871 @default.
• W2012309329 cites W2010524294 @default.
• W2012309329 cites W2014344114 @default.
• W2012309329 cites W2016195188 @default.
• W2012309329 cites W2016950157 @default.
• W2012309329 cites W2017692041 @default.
• W2012309329 cites W2017755728 @default.
• W2012309329 cites W2018685742 @default.
• W2012309329 cites W2019052929 @default.
• W2012309329 cites W2020498032 @default.
• W2012309329 cites W2021469759 @default.
• W2012309329 cites W2022161896 @default.
• W2012309329 cites W2022612163 @default.
• W2012309329 cites W2022627623 @default.
• W2012309329 cites W2028066084 @default.
• W2012309329 cites W2030510604 @default.
• W2012309329 cites W2031165402 @default.
• W2012309329 cites W2032768676 @default.
• W2012309329 cites W2033510997 @default.
• W2012309329 cites W2038006225 @default.
• W2012309329 cites W2039422087 @default.
• W2012309329 cites W2040080115 @default.
• W2012309329 cites W2040766695 @default.
• W2012309329 cites W2042613868 @default.
• W2012309329 cites W2043912950 @default.
• W2012309329 cites W2044740646 @default.
• W2012309329 cites W2044897807 @default.
• W2012309329 cites W2045640696 @default.
• W2012309329 cites W2047348947 @default.

• next